Snacks have long relied on habit, craving, and convenience, but GLP-1 weight loss drugs are beginning to reshape how and what consumers eat. Appetite suppression and portion control are influencing demand across snacks, packaged foods, and beverages. This analysis explores how the food industry is responding to a health-led shift in consumption behavior. Backed by data-driven thinking... https://www.indigrowth.com/weight-loss-pills-are-eating-snack-sales/